Polypeptides, antibody variable domains & antagonists

Details for Australian Patent Application No. 2009319175 (hide)

Owner Glaxo Group Limited

Inventors Catchpole, Ian Richard; Cook, Fiona; Gough, Gerald Wayne; Jespers, Laurent; Steward, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009319175

PCT Pub. Number WO2010/060768

Priority 12/323,632 26.11.08 US

Filing date 4 November 2009

Wipo publication date 3 June 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/02 (2006.01) Drugs for disorders of the senses

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/060768 Priority application(s): WO2010/060768

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319183-Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations

2009319167-Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester